Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2009 1
2010 1
2012 1
2013 2
2014 1
2015 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Denosumab for prevention of fractures in postmenopausal women with osteoporosis.
Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, Delmas P, Zoog HB, Austin M, Wang A, Kutilek S, Adami S, Zanchetta J, Libanati C, Siddhanti S, Christiansen C; FREEDOM Trial. Cummings SR, et al. N Engl J Med. 2009 Aug 20;361(8):756-65. doi: 10.1056/NEJMoa0809493. Epub 2009 Aug 11. N Engl J Med. 2009. PMID: 19671655 Free article. Clinical Trial.
Impact of osteoporosis and osteoporosis medications on fracture healing: a narrative review.
Chandran M, Akesson KE, Javaid MK, Harvey N, Blank RD, Brandi ML, Chevalley T, Cinelli P, Cooper C, Lems W, Lyritis GP, Makras P, Paccou J, Pierroz DD, Sosa M, Thomas T, Silverman S; Fracture Working Group of the Committee of Scientific Advisors of the International Osteoporosis Foundation, on behalf of the International Osteoporosis Foundation, Société Internationale de Chirurgie Orthopédique et de Traumatologie. Chandran M, et al. Osteoporos Int. 2024 Apr 8. doi: 10.1007/s00198-024-07059-8. Online ahead of print. Osteoporos Int. 2024. PMID: 38587674 Review.
Review of treatment modalities for postmenopausal osteoporosis.
Hamdy RC, Chesnut CH 3rd, Gass ML, Holick MF, Leib ES, Lewiecki ME, Maricic M, Watts NB. Hamdy RC, et al. Among authors: lewiecki me. South Med J. 2005 Oct;98(10):1000-14; quiz 1015-7, 1048. doi: 10.1097/01.smj.0000184921.53062.bf. South Med J. 2005. PMID: 16295815 Review.
Worldwide uptake of FRAX.
Kanis JA, Johansson H, Oden A, Cooper C, McCloskey EV; Epidemiology and Quality of Life Working Group of IOF. Kanis JA, et al. Arch Osteoporos. 2014;9:166. doi: 10.1007/s11657-013-0166-8. Epub 2014 Jan 14. Arch Osteoporos. 2014. PMID: 24420978
Standardising the descriptive epidemiology of osteoporosis: recommendations from the Epidemiology and Quality of Life Working Group of IOF.
Kanis JA, Adachi JD, Cooper C, Clark P, Cummings SR, Diaz-Curiel M, Harvey N, Hiligsmann M, Papaioannou A, Pierroz DD, Silverman SL, Szulc P; Epidemiology and Quality of Life Working Group of IOF. Kanis JA, et al. Osteoporos Int. 2013 Nov;24(11):2763-4. doi: 10.1007/s00198-013-2413-7. Epub 2013 Jul 25. Osteoporos Int. 2013. PMID: 23884436 Free PMC article.
Lasofoxifene in postmenopausal women with osteoporosis.
Cummings SR, Ensrud K, Delmas PD, LaCroix AZ, Vukicevic S, Reid DM, Goldstein S, Sriram U, Lee A, Thompson J, Armstrong RA, Thompson DD, Powles T, Zanchetta J, Kendler D, Neven P, Eastell R; PEARL Study Investigators. Cummings SR, et al. N Engl J Med. 2010 Feb 25;362(8):686-96. doi: 10.1056/NEJMoa0808692. N Engl J Med. 2010. PMID: 20181970 Free article. Clinical Trial.
A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: the Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) trial.
Binkley N, Bolognese M, Sidorowicz-Bialynicka A, Vally T, Trout R, Miller C, Buben CE, Gilligan JP, Krause DS; Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) Investigators. Binkley N, et al. J Bone Miner Res. 2012 Aug;27(8):1821-9. doi: 10.1002/jbmr.1602. J Bone Miner Res. 2012. PMID: 22437792 Free article. Clinical Trial.